Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort studyEiso Hiyama, Megu Ohtaki, Masahiko Sugiyama et al.|The Lancet|2008Cited by 126
Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratificationEiso Hiyama, Megu Ohtaki, Hiroaki Yamaoka et al.|Pediatric Surgery International|2007Cited by 4
IS-3 Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification(International Session1)Eiso Hiyama, Megu Ohtaki, Kouhei Akazawa et al.|日本小児外科学会雑誌|2006Cited by 0